Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene (Q43917987)

28 November 2017

title

Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene (English)

1 reference

28 November 2017

1 reference

Wybranietz WA

1

1 reference

28 November 2017

Gross CD

2

1 reference

28 November 2017

Phelan A

3

1 reference

28 November 2017

O'Hare P

4

1 reference

28 November 2017

Spiegel M

5

1 reference

28 November 2017

Graepler F

6

1 reference

28 November 2017

Bitzer M

7

1 reference

28 November 2017

Stähler P

8

1 reference

28 November 2017

Gregor M

9

1 reference

28 November 2017

Lauer UM

10

1 reference

28 November 2017

publication date

1 November 2001

1 reference

28 November 2017

1 reference

28 November 2017

volume

8

1 reference

28 November 2017

issue

21

1 reference

28 November 2017

page(s)

1654-1664

1 reference

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Evaluation of VP22 spread in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Direct protein transfer to terminally differentiated muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Understanding, improving and using green fluorescent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

7 January 2021

Growth characteristics and imaging properties of the morris hepatoma 3924A in ACI rats: a suitable model for transarterial chemoembolization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

7 January 2021

Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

7 January 2021

Distinct combination of purification methods dramatically improves cohesive-end subcloning of PCR products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301564

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301564

1 reference

Dimensions Publication ID

28 November 2017

1015199908

0 references

1 reference